Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell TransplantationFrancisco M. Marty, Cyrus Badshah, Per Ljungman et al.|New England Journal of Medicine|2017Cited by 1.2k
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantationTetsuichi Yoshizato, Seishi Ogawa, Nobuyuki Kakiuchi et al.|Blood|2017Cited by 352
Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndromeK Nakai, Shingo Kato, Yoshinobu Kanda et al.|Leukemia|2005Cited by 119
Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host DiseaseSaiko Kurosawa, Yoshiko Atsuta, Kumi Oshima et al.|Biology of Blood and Marrow Transplantation|2017Cited by 116
Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine modelsKiyomi Mashima, Yoshinobu Kanda|PLoS ONE|2021Cited by 9